Author: max

Explore the key factors contributing to W.P. Carey’s 16% decline in 2024, including market trends, economic challenges, and operational adjustments.

Johnson & Johnson acquires Intra-Cellular Therapeutics for $14.6 billion, enhancing its portfolio in innovative therapies and expanding its market reach.

Discover the top 3 dividend stocks to invest in for 2025, offering strong returns and reliable income for savvy investors.

Walgreens stock surges—explore whether it’s still a smart investment choice and what factors could influence its future performance.

Goldman Sachs restructures to sharpen its financing focus, aiming to boost efficiency and adapt to changing market demands, reports WSJ.